Schulze, Nicole Werpy, Natasha Gernhardt, Jennifer Fritsch, Guido Hildebrandt, Thomas Vanderperren, Katrien Klopfleisch, Robert Ben Romdhane, Racem Lischer, Christophorus Ehrle, Anna
...
Published in
Equine veterinary journal
Dynamic computed tomography (CT) imaging has been introduced in human orthopaedics and is continuing to gain popularity. With dynamic CT, video sequences of anatomical structures can be evaluated in motion. To investigate the feasibility of dynamic CT for diagnostic imaging of the equine cervical articular process joints (APJs) and to give a detail...
Wagner, Jessica; Degenhardt, Karoline; Veit, Marleen; Louros, Nikolaos; 110886; Konstantoulea, Katerina; 122673; Skodras, Angelos; Wild, Katleen; Liu, Ping; Obermueller, Ulrike; Bansal, Vikas;
...
Aggregates of medin amyloid (a fragment of the protein MFG-E8, also known as lactadherin) are found in the vasculature of almost all humans over 50 years of age1,2, making it the most common amyloid currently known. We recently reported that medin also aggregates in blood vessels of ageing wild-type mice, causing cerebrovascular dysfunction3. Here ...
Schaeverbeke, Jolien; 92930; Tome, Sandra O; Ronisz, Alicja; 53975; Ospitalieri, Simona; von Arnim, Christine AF; Otto, Markus; Vandenberghe, Rik; 5277; Thal, Dietmar Rudolf; 97737;
INTRODUCTION: Imaging studies indicated basal forebrain reduction in primary progressive aphasia (PPA), which might be a candidate marker for cholinergic treatment. Nucleus basalis of Meynert (nbM) neuronal loss has been reported, but a systematic quantitative neuropathological assessment including the three clinical PPA variants is lacking. METHOD...
Deleersnijder, Dries; 141152; Laurens, Wim; De Meester, Johan; Cleenders, Evert; 138877; Dendooven, Amelie; Lerut, Evelyne; De Vriese, An S; Dejagere, Tom; Helbert, Mark; Hellemans, Rachel;
...
status: published
Possemiers, Hendrik; 116996; Pollenus, Emilie; 123298; Prenen, Fran; Knoops, Sofie; Koshy, Priyanka; van den Steen, Philippe EE; 6959;
Malaria remains a important global disease with more than 200 million cases and 600 000 deaths each year. Malaria-associated acute kidney injury (MAKI) may occur in up to 40% of patients with severe malaria and is associated with increased mortality. Histopathological characteristics of AKI in malaria are acute tubular injury, interstitial nephriti...
Enax-Krumova, Elena K; Dahlhaus, Iris; Goerlach, Jonas; Claeys, Kristl G; 35304; Montagnese, Federica; Schneider, Llka; Sturm, Dietrich; Fangerau, Tanja; Schlierbach, Hannah; Roth, Angela;
...
BACKGROUND: Pain occurs in the majority of patients with late onset Pompe disease (LOPD) and is associated with a reduced quality of life. The aim of this study was to analyse the pain characteristics and its relation to a small nerve fiber involvement in LOPD patients. METHODS: In 35 patients with LOPD under enzyme replacement therapy without clin...
Yang, Mei-Ling; Horstman, Sheryl; Gee, Renelle; Guyer, Perrin; Lam, TuKiet T; Kanyo, Jean; Perdigoto, Ana L; Speake, Cate; Greenbaum, Carla J; Overbergh, Lut; 16266;
...
Inflammation, including reactive oxygen species and inflammatory cytokines in tissues amplify various post-translational modifications of self-proteins. A number of post-translational modifications have been identified as autoimmune biomarkers in the initiation and progression of Type 1 diabetes. Here we show the citrullination of pancreatic glucok...
Deans, Zandra C; Ahn, Joo Wook; Carreira, Isabel M; Dequeker, Elisabeth; 10260; Henderson, Mick; Lovrecic, Luca; Ounap, Katrin; Tabiner, Melody; Treacy, Rebecca; van Asperen, Christi J;
...
Results of clinical genomic testing must be reported in a clear, concise format to ensure they are understandable and interpretable. It is important laboratories are aware of the information which is essential to make sure the results are not open to misinterpretation. As genomic testing has continued to evolve over the past decade, the European So...
Vanuytsel, T; 64222; Reenaers, C;
status: published
Karran, Eric; De Strooper, Bart; 12249;
Many drugs that target amyloid-β (Aβ) in Alzheimer disease (AD) have failed to demonstrate clinical efficacy. However, four anti-Aβ antibodies have been shown to mediate the removal of amyloid plaque from brains of patients with AD, and the FDA has recently granted accelerated approval to one of these, aducanumab, using reduction of amyloid plaque ...